Publicaciones en las que colabora con Maria Angeles Muñoz Fernandez (20)

2018

  1. Estrogen receptor-alpha (ESR1) governs the lower female reproductive tract vulnerability to Candida albicans

    Frontiers in Immunology, Vol. 9, Núm. MAY

2016

  1. Sex hormones coordinate neutrophil immunity in the vagina by controlling chemokine gradients

    Journal of Infectious Diseases, Vol. 213, Núm. 3, pp. 476-484

2013

  1. Female sex hormones regulate the Th17 immune response to sperm and Candida albicans.

    Human reproduction (Oxford, England), Vol. 28, Núm. 12, pp. 3283-3291

2005

  1. HIV-1 infection of neurons might account for progressive HIV-1-associated encephalopathy in children

    Journal of Molecular Neuroscience, Vol. 27, Núm. 1, pp. 79-90

2004

  1. Short-term sequential analysis of sex hormones and helper T cells type 1 (Th1) and helper T cells type 2 (Th2) cytokines during and after multiple sclerosis relapse

    European Cytokine Network, Vol. 15, Núm. 3, pp. 197-202

  2. The effects on infants of potent antiretroviral therapy during pregnancy: A report from Spain

    Medical Science Monitor, Vol. 10, Núm. 5

2003

  1. CD8+ T-cell numbers predict the response to antiviral therapy in HIV-1-infected children

    Pediatric Research, Vol. 53, Núm. 2, pp. 309-312

  2. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

    Pediatrics, Vol. 111, Núm. 2

  3. Reconstitución clínica e inmunológica completa tras el tratamiento antirretroviral de gran actividad en un niño infectado verticalmente por el virus de la inmunodeficiencia humana tipo 1 con enfermedad avanzada

    Medicina Clinica, Vol. 120, Núm. 11, pp. 417-420

  4. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers

    Clinical and Experimental Immunology, Vol. 131, Núm. 1, pp. 130-137

2002

  1. Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS

    AIDS Research and Human Retroviruses, Vol. 18, Núm. 18, pp. 1395-1406

  2. Immunological recovery after 3 years' antiretroviral therapy in HIV-1-infected children

    AIDS, Vol. 16, Núm. 3, pp. 483-486

  3. Impact of antiretroviral protocols on dynamics of AIDS progression markers

    Archives of Disease in Childhood, Vol. 86, Núm. 2, pp. 119-124

  4. Reconstructing the course of HIV-1-associated progressive encephalopathy in children

    Medical Science Monitor, Vol. 8, Núm. 10

  5. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis

    European Cytokine Network, Vol. 13, Núm. 1, pp. 110-114

2001

  1. Factor de necrosis tumoral (TNF-α) en el diagnóstico de meningitis neonatal bacteriana o aséptica

    Acta Pediatrica Espanola, Vol. 59, Núm. 7, pp. 374-378

  2. Impaired interleukin-5 (IL-5) production by T cells as a prognostic marker of disease progression in human immunodeficiency virus type 1 (HIV-1)-infected children

    European Cytokine Network, Vol. 12, Núm. 2, pp. 253-259

2000

  1. Clinical relevance of cytokine production in HIV-1 infection in children on antiretroviral therapy

    Scandinavian Journal of Immunology, Vol. 52, Núm. 6, pp. 634-640

1999

  1. Adenoidal tissue mass as a clinical guide of disease evolution in vertically HIV-1 infected children

    International Journal of Pediatric Otorhinolaryngology, Vol. 51, Núm. 3, pp. 145-155

  2. Correlation of viral load and CD8 T-lymphocytes with development of neurological manifestations in vertically HIV-1-lnfected infants. A prospective longitudinal study

    Neuropediatrics, Vol. 30, Núm. 4, pp. 197-204